A randomized, double blind, placebo controlled, parallel group trial for assessing the clinical benefit of Dronedarone 400mg BID on top of standard therapy in patients with permanent atrial fibrillation and additional risk factors

Authors
Category Primary study
Registry of TrialsOverview of Medical Research in the Netherlands
Year 2010
This article has no abstract
Epistemonikos ID: e6205732ebdfb868da5d59a25970844c34b6380c
First added on: Apr 16, 2025